New Delhi: The drug price regulator has sought details of patented medicines as part of a drive to fix their rates.
The National Pharmaceutical Pricing Authority (NPPA) is also fixing the price ceiling for 102 drugs on the National List of Essential Medicines (NLEM) and has asked for financial data, like retail rates and the firms’ turnover.
On patented drugs imported or manufactured for sale in India, the NPPA has called for details such as therapeutic use, current price and date of patent grant and expiry. The move comes after an inter-ministerial panel on such drugs met earlier this month.